Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

329

HTML

2635

Figures (1-10)

218

Sum=3182

Jun 7, 2005 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3204-3211
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3204

Full Size Figure Download Figure

Figure 3 RT-PCR analysis of FasL expression in SGC-7901/FB-11 and SGC-7901. A: SGC-7901/FB-11; B: SGC-7901; C: DNA Marks.

Citation: Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells. World J Gastroenterol 2005; 11(21): 3204-3211
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3204.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3204